OptimizeRx (OPRX) Form 4: Tax withholdings of 414 and 794 shares
OptimizeRx Corp (OPRX) reported insider activity on Form 4 for its Chief Business Officer.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
OptimizeRx Corp (OPRX) reported insider activity on Form 4 for its Chief Business Officer. The filing shows issuer tax withholdings (Transaction Code F) related to equity compensation. On 10/01/2025, 414 shares of common stock were withheld at $18.98. On 10/03/2025, 794 shares were withheld at $18.75. Following these transactions, the reporting person held 46,306 shares directly. The explanation states the shares were withheld by the issuer to satisfy tax obligations and are treated as dispositions under Section 16.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 794 | $18.75 | $15K |
| Exercise Price or Tax Liability | Common Stock | 414 | $18.98 | $8K |
Footnotes (1)
- F1. These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did OPRX disclose on this Form 4?
Who is the reporting person and their role at OPRX?
What does Transaction Code F mean in this context?
Are these open-market sales by the officer?
AI-generated analysis. How Rhea-AI works. Not financial advice.